The Treatment of Tuberculous Empyemas with TYROTHRICIN (cas 1404-88-2)
-
Add time:09/05/2019 Source:sciencedirect.com
Eight patients with tuberculous empyema were treated with tyrothricin in amounts varying from 10 to 50 mg. The temperature was elevated following the instillation of this drug in all cases. In three cases chest pain was experienced and one patient complained of dyspnea eight hours after the instillation of tyrothricin. Tyrothricin did not alter the character nor the amount of the purulent exudate.
We also recommend Trading Suppliers and Manufacturers of TYROTHRICIN (cas 1404-88-2). Pls Click Website Link as below: cas 1404-88-2 suppliers
Prev:Research ArticlesA Rapid HPLC Method for the Quantification of TYROTHRICIN (cas 1404-88-2), Menthol, and Benzocaine in Pharmaceutical Formulations
Next:ArticlesEffect of Actamer® and TYROTHRICIN (cas 1404-88-2) on Oral Microorganisms) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- ArticlesA Routine Method for the In Vitro Assay of TYROTHRICIN (cas 1404-88-2)09/09/2019
- Original articleStudies to determine the ability of TYROTHRICIN (cas 1404-88-2) to sensitize the skin09/08/2019
- Characterisation of the tyrocidine and gramicidin fractions of the TYROTHRICIN (cas 1404-88-2) complex from Bacillus brevis using liquid chromatography and mass spectrometry☆09/07/2019
- ArticlesEffect of Actamer® and TYROTHRICIN (cas 1404-88-2) on Oral Microorganisms09/06/2019
- Research ArticlesA Rapid HPLC Method for the Quantification of TYROTHRICIN (cas 1404-88-2), Menthol, and Benzocaine in Pharmaceutical Formulations09/04/2019
- An investigation of the TYROTHRICIN (cas 1404-88-2) complex by tandem mass spectrometry09/03/2019
- Development and validation of chromatographic methods (HPLC and GC) for the determination of the active components (benzocaine, TYROTHRICIN (cas 1404-88-2) and menthol) of a pharmaceutical preparation09/02/2019
- FluorescenceIndividual and joint stopped flow kinetic spectrofluorimetric determination of neomycin and TYROTHRICIN (cas 1404-88-2)09/01/2019